Pha maco the apeutic Evaluation o Rudantyadi Yog (Kalpit Yog) in Management o adhu eha

Abstract

Diabetes Mellitus is one of the world's major diseases. The WHO additionally assesses that 80%  of diabetes passing happen in low and centre salary nations. As per a World Health Organization (WHO)  reality sheet on diabetes, an expected 3.4 million passing’s are caused because of high blood sugar. It has  been additionally evaluated that the worldwide weight of type-2 diabetes is relied upon to increment to 438  million by 2030 from 285 million individuals (recorded in 2010). So additionally, for India this extension is  surveyed to be 58%, from 51 million people in 2010 to 87 million out of 2030. It is a well known fact that oral hypoglycemic agents used in modern medicine only maintains the normal blood glucose level & when used lifelong cause various adverse effects like Hypoglycemia. So current clinical study is planned to evaluate the “Pharmaco-therapeutic Evaluation of Rudantyadi Yog (Kalpit Yog) in Management of Madhumeha”. The study was conducted on 40 clinically diagnosed patients of Madhumeha. They are randomly allocated  into two groups after screening. Group-A (Rudantyadi Yog) a trial group medicine & Group-B (Mamajjak  Ghan Vati) a control group medicine. Observation & result assessed on the basis of difference in the score  of sign and symptoms. All the details regarding the study are further detailed.